Avenue Therapeutics Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Alix MacLean
Chief executive officer
US$1.2m
Total compensation
| CEO salary percentage | 33.0% |
| CEO tenure | 1.8yrs |
| CEO ownership | n/a |
| Management average tenure | 2.2yrs |
| Board average tenure | 5.2yrs |
Recent management updates
Recent updates
Avenue Therapeutics shares slide on pricing $12M securities offering
Oct 07Avenue Therapeutics up 4% on 1-for-15 reverse stock split
Sep 22Avenue Therapeutics shares fall after FDA declines to approve IV tramadol pain medicine
Jun 14We're Keeping An Eye On Avenue Therapeutics' (NASDAQ:ATXI) Cash Burn Rate
Mar 19
How Many Avenue Therapeutics, Inc. (NASDAQ:ATXI) Shares Do Institutions Own?
Jan 23We're Keeping An Eye On Avenue Therapeutics' (NASDAQ:ATXI) Cash Burn Rate
Dec 19Avenue Therapeutics issues regulatory update for IV tramadol
Dec 17CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$1m | US$400k | -US$10m |
| Sep 30 2023 | n/a | n/a | -US$10m |
| Jun 30 2023 | n/a | n/a | -US$12m |
| Mar 31 2023 | n/a | n/a | -US$8m |
| Dec 31 2022 | US$516k | US$154k | -US$4m |
Compensation vs Market: Alix's total compensation ($USD1.21M) is above average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: Alix's compensation has increased whilst the company is unprofitable.
CEO
Alix MacLean (55 yo)
1.8yrs
Tenure
US$1,213,200
Compensation
Dr. Alexandra MacLean, also known as Alix, MD, serves as Director of Kent Imaging Inc. since January 2021. She is Chief Executive Officer at Avenue Therapeutics, Inc. since August 01, 2022 and serves as it...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.8yrs | US$1.21m | no data | |
| Interim CFO | 2.2yrs | US$260.00k | 0% $ 0 | |
| Executive Director | 1.2yrs | US$104.00k | 0.79% $ 23.4k | |
| Consultant | 2.2yrs | US$1.05m | no data | |
| Interim Chief Medical Officer | 8.3yrs | US$123.12k | no data | |
| Executive Vice President | no data | no data | no data |
2.2yrs
Average Tenure
53.5yo
Average Age
Experienced Management: ATXI's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.2yrs | US$1.21m | no data | |
| Executive Director | 9.3yrs | US$104.00k | 0.79% $ 23.4k | |
| Chairman of the Board | 7.3yrs | US$212.19k | 0.020% $ 596.1 | |
| Non-Executive Independent Director | 8.8yrs | US$60.00k | 0.020% $ 596.1 | |
| Independent Director | 2yrs | US$154.00k | 0% $ 0 | |
| Independent Director | 3.1yrs | US$154.00k | 0.0075% $ 220.6 |
5.2yrs
Average Tenure
64yo
Average Age
Experienced Board: ATXI's board of directors are considered experienced (5.2 years average tenure).